| Document Date: 2010-07-09 15:00:30
Open Document File Size: 331,73 KBShare Result on Facebook
Company CCR’s Laboratory / Interestingly / Kreitman / / Country United States / / Event FDA Phase / Person Travel / / Facility NIH Clinical Center / CCR’s Laboratory of Molecular Biology / / IndustryTerm immune systems / treatment of the spread of ovarian cancer / poor vascular and lymphatic systems / cancer therapies / energy / classic car / / MedicalCondition hairy cell leukemia / prevented lung metastases / ovarian cancer / bulky tumors / hematological malignancies / prostate cancers / Solid Tumors / cell lymphomas / dramatic tumor / ian cancer / fatigue / mesotheliomas / certainly ovarian cancer / CD25-expressing hematological malignancies / leukemias / prostate cancer / protection solid tumors / pancreatic cancer / count prostate cancer / both cancers / cancers / tumor / breast cancers / cancer / tumors / disease / rare cancer / also made tumors / Phase leukemia / hematologic malignancies / recurrent mesothelioma / T-cell cancers / lung adenocarcinomas / infection / From Dangerous Fatigue / inflammation / kill cancer / gastric and pancreatic cancers / / MedicalTreatment chemotherapy / Immunotherapy / anti-cancer therapies / CCR / / Organization National Institute of Health / NIH Clinical Center / Wake Forest University School / / Person David J / Raffit Hassan / Ira Pastan / Tapan Bera / Robert J. Kreitman / Dave Brenneman / Mark Willingham / / Position physician / Scientist / Head / Chief / engineer / Head of the LMB research / / Product cladribine / Taxol / HA22 / CA-125 / SS1P / / ProvinceOrState Prince Edward Island / Pennsylvania / / PublishedMedium Molecular Biology / / SportsEvent NHL / / Technology genetic engineering / antibodies / stem cells / chemotherapy / /
SocialTag |
A Better Immunotoxin Through inspired engineering, proteins that enter and kill cancer cells are finding their place among cancer treatments. (Photo: R. Baer)